Skip to content

Clinical trials

Phase 1/2 Cardiomyopathy, Dilated trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiomyopathy, Dilated Phase: Phase 1/2 Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20072
20101
20111
20121
20131
20181
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting3
Unknown status2
Not yet recruiting1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Affinia Therapeutics1
Bristol-Myers Squibb1
Celladon Corporation1
Heartseed Inc.1
Henry M. Spotnitz1
Hospital General Universitario Gregorio Marañon1
Instituto de Cardiologia do Rio Grande do Sul1
Johann Wolfgang Goethe University Hospital1
Joshua M Hare1
Nuevocor Pte. Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiomyopathy, Dilated14
Heart Failure9
Cardiomyopathies2
Cardiovascular Diseases1
Coronary Disease1
Heart Diseases1
Myocardial Ischemia1

Trials

Showing 26 to 14 of 14. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.